Silvers Jason
President & CFO
Silvers Jason has filed 1 SEC Form 4 filing (3 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Mar 2, 2026.
On the most recent filing, Silvers Jason is listed as President & CFO at Generate Biomedicines, Inc. Inside the rolling window, Silvers Jason reported 1 open-market purchase totaling $24K in GENB and no open-market sales.
Companies traded
Other insiders at GENB
Insider Buying
$24K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Silvers Jason made?
Silvers Jason has filed 1 SEC Form 4 filing (3 transaction rows) across 1 company since 2026.
Which companies does Silvers Jason trade?
Silvers Jason has filed SEC Form 4 disclosures for 1 company, including GENB.
When was Silvers Jason's most recent SEC Form 4 filing?
Silvers Jason's most recent SEC Form 4 filing on Tracefour is dated Mar 2, 2026.
What is Silvers Jason's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Silvers Jason is listed as President & CFO.
What is Silvers Jason's total buy and sell value in the current window?
Inside the rolling retention window, Silvers Jason bought $24K and sold $0 based on SEC Form 4 filings.
What was Silvers Jason's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 1,500 GENB shares on 2026-03-02, worth $24K, per SEC Form 4 filings.